We were delighted to speak with Prof. Christopher Butler (University of Oxford, Oxford, UK) about antiviral therapies for influenza and, in particular, the findings from the ALIC4E trial.
1. What are the current recommendations for the use of antiviral therapy for the treatment of influenza? (0:07)
2. Why is oseltamivir not more widely used in the treatment of influenza? (1:00)
3. Could you tell us a little about the ALIC4E clinical trial design and its findings in terms of who is most likely to benefit? (2:32)
4. What other studies are ongoing/are planned? (5:18)
Speaker disclosure: Christopher Butler is the principal investigator of the ALIC4E clinical trial.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress 2020.
Share this Video
Related Videos In Respiratory Infections
Francesca Conradie, World Conference on Lung Health 2022: A delamanid-bedaquiline regimen for rifampicin-resistant tuberculosis- findings from BEAT tuberculosis
BEAT tuberculosis (NCT04062201) investigated treatment with a short course of a delamanid-bedaquiline regimen for rifampicin resistant tuberculosis (RR-TB) in South Africa. It was a pleasure to talk with Dr Francesca Conradie (University of the Witwatersrand, Johannesburg, South Africa) around the aims and design of the BEAT tuberculosis study and the findings from the interim analysis. […]
Véronique Suttels, World Conference on Lung Health 2022: Point-of-care ultrasound as a potential triage tool for tuberculosis (Part 2)
Point-of-care ultrasound (POCUS) is a potential triage tool for tuberculosis (TB) that could allow non-specialist healthcare workers to guide decision-making in TB management. In this touchRESPIRATORY interview, we speak with Dr. Veronique Suttels (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) to discuss the intermediate analysis of the study investigating POCUS in Benin and the potential impact […]
Véronique Suttels, World Conference on Lung Health 2022: Point-of-care ultrasound as a potential triage tool for tuberculosis (Part 1)
Pulmonary tuberculosis (TB) is a contagious infectious disease caused by Mycobacterium tuberculosis, symptoms can include a cough, chest pain and breathlessness, and in some cases the infection can spread to other organs. In this touchRESPIRATORY interview, we speak with Dr. Veronique Suttels (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) to discuss the strengths and limitations of […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!